Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma

Primary open-angle glaucoma (OAG) affects approximately 45 million people worldwide and more than 2.5 million people aged 40 years or older in the United States. Pharmacologic treatment for glaucoma is directed towards lowering intraocular pressure (IOP) to slow disease progression and delay visual...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Louise J., Tsai, James C., Liu, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369028/
https://www.ncbi.nlm.nih.gov/pubmed/28356898

Ejemplares similares

Ejemplares similares